I still stand by my belief that the interim analysis results released before end of march will be HUGE. Until then, I don't think much will happen. MSB tends to go down in absence of announcements. I listened to one of the webcasts last night (not sure which one), but Silviu said something along the lines of how positive interim analysis results will be used to get fast track product approval under the cures act and also to get another Partnership (possibly Celgene).
But until end of March we are just waiting.
MSB as "the Next CSL", page-22
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.025(2.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 97.0¢ | $1.01 | 96.5¢ | $7.757M | 7.884M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 274918 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 974 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |